Literature DB >> 24675497

Assessment of impact of late postoperative physical functional disabilities on quality of life in breast cancer survivors.

Renata Cristina Martins da Silva, Laura Ferreira Rezende.   

Abstract

AIMS AND
BACKGROUND: Breast cancer is the second most common malignancy among women. Surgical and supplemental (or adjuvant) therapies to combat the disease may implicate physical functional consequences for the ipsilateral upper extremity. These dysfunctions may persist for many years and have repercussions on the performance of daily living activities. The aim of this study was to assess the impact of physical functional disabilities on quality of life in women after breast cancer surgery. METHODS AND STUDY
DESIGN: Eighty-two women in the postoperative period of conservative surgery for breast cancer participated in the study. Axillary lymph node dissection was performed in all patients and mean time since surgery was 5.78 (± 4.60) years. The women responded to a questionnaire to assess quality of life (FACT-B) and to another to assess functional capacity (QuickDASH). They were then referred to physical therapy examination to measure shoulder range of motion (flexion, abduction and external rotation) and arm volume.
RESULTS: Range of motion in the ipsilateral shoulder was limited: shoulder flexion range of motion reached a mean value of 155.44º (± 28.31), mean abduction was 149.05º (± 29.51), and mean external shoulder rotation was 58.44º (± 29.17). These limitations had a negative impact on functional capacity and global quality of life. Lymphedema was present in 28.04% of women assessed and did not impair quality of life or functional capacity.
CONCLUSION: Physical functional disabilities were present in the late postoperative period of breast cancer survivors and limited shoulder range of motion negatively influenced their functional capacity and quality of life. The presence of lymphedema did not impair functional capacity or quality of life in the postoperative period.

Entities:  

Mesh:

Year:  2014        PMID: 24675497     DOI: 10.1700/1430.15821

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916            Impact factor:   2.098


  6 in total

1.  Effects of warm acupuncture on breast cancer-related chronic lymphedema: a randomized controlled trial.

Authors:  C Yao; Y Xu; L Chen; H Jiang; C S Ki; J S Byun; W Bian
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

Review 2.  Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review.

Authors:  L H Eaton; N Narkthong; J M Hulett
Journal:  Curr Breast Cancer Rep       Date:  2020-08-25

3.  Predictors of Altered Upper Extremity Function During the First Year After Breast Cancer Treatment.

Authors:  Betty Smoot; Steven M Paul; Bradley E Aouizerat; Laura Dunn; Charles Elboim; Brian Schmidt; Deborah Hamolsky; Jon D Levine; Gary Abrams; Judy Mastick; Kimberly Topp; Christine Miaskowski
Journal:  Am J Phys Med Rehabil       Date:  2016-09       Impact factor: 2.159

4.  Effects of a physical therapy program combined with manual lymphatic drainage on shoulder function, quality of life, lymphedema incidence, and pain in breast cancer patients with axillary web syndrome following axillary dissection.

Authors:  Youngki Cho; Junghwa Do; Sunyoung Jung; Ohyun Kwon; Jae Yong Jeon
Journal:  Support Care Cancer       Date:  2015-11-05       Impact factor: 3.359

5.  Effect of complete decongestive therapy and home program on health- related quality of life in post mastectomy lymphedema patients.

Authors:  Ganeswara Rao Melam; Syamala Buragadda; Adel A Alhusaini; Nisha Arora
Journal:  BMC Womens Health       Date:  2016-05-04       Impact factor: 2.809

Review 6.  Extracorporeal Shock Wave Therapy Combined with Complex Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema: A Systemic Review and Meta-Analysis.

Authors:  Yu Lin Tsai; Ting Jie I; Ya Chi Chuang; Yuan Yang Cheng; Yu Chun Lee
Journal:  J Clin Med       Date:  2021-12-19       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.